Stocks › TGEN

TECOGEN INC.

TGEN·NYSE·United States United States·USD
$1.54
-0.18 (-10.47%)
Close · Nov 20, 2026 · Close Prices from Tiingo.com
TGEN
TECOGEN INC. · NYSE
Nasdaq 100S&P 500
Filings
Default90D1Y5YALL
TGENS&P 500 (rebased)
Congress BuyCongress SellInsider BuyInsider SellForm 1448-K ResultsLobbying
Loading price history…
Daily closes, adjusted for splits and dividends · Close Prices from Tiingo.comHover a marker, every one is a filing · move across the line for the crosshair

Congressional Trades

Recent trades of TGEN by members of U.S. Congress · 0 on record

No congressional trades in TGEN on record.

Whale Activity

Position changes in TGEN reported for 2026-09-30 by 76 institutional filers
Increased: 19New: 8Held: 10Decreased: 17Closed: 21No prior filing: 1
  • Increased19
  • New8
  • Held10
  • Decreased17
  • Closed21
  • No prior filing1
FilerSharesValueChange
Portolan Capital Management, LLC1.2M$3.4Mdecreased
VANGUARD CAPITAL MANAGEMENT LLC780.0K$2.2Mdecreased
BARD ASSOCIATES INC676.3K$1.9Mdecreased
Clear Harbor Asset Management, LLC650.0K$1.8Mheld
Meros Investment Management, LP516.9K$1.5Mincreased
UBS Group AG378.9K$1.1Mincreased
HEARTLAND ADVISORS INC378.5K$1.1Mincreased
RAYMOND JAMES FINANCIAL INC359.1K$1.0Mincreased
MORGAN STANLEY354.9K$1.0Mincreased
SUSQUEHANNA INTERNATIONAL GROUP, LLP309.3K$878Kdecreased
Aberdeen Group plc281.4K$799Knew
Palisades Investment Partners, LLC269.2K$765Kdecreased

Every 13F filer's complete reported book, every quarter since 2013-06-30. 13F itself excludes short positions, cash and most options.

Insider Trading

Net shares bought (+) or sold (−) on the open market by TGEN insiders, by quarter · Form 4
-100.0K-50.0K050.0K100.0K2025 Q1: 4002025 Q12025 Q2: -60.0K2025 Q22025 Q3: 02025 Q32025 Q4: 02025 Q42026 Q1: 43.0K2026 Q12026 Q2: 17.7K2026 Q22026 Q3: 02026 Q32026 Q4: 46.5K2026 Q4

Recent Insider Transactions

312 transactions on record · newest first
All insider activity →
InsiderTypeSharesPriceValueDate
Hirsch Susan BDirector · Director Purchase +10.0K $1.64 $16K Nov 20, 2026 Form 4 ↗
Rangesh AbinandChief Executive Officer · Director Purchase +1,500 $1.75 $3K Nov 19, 2026 Form 4 ↗
Hatsopoulos JohnDirector · Director Purchase +2,000 $1.71 $3K Nov 19, 2026 Form 4 ↗
Hatsopoulos JohnDirector · Director Purchase +2,000 $1.72 $3K Nov 19, 2026 Form 4 ↗
Hatsopoulos JohnDirector · Director Purchase +1,000 $1.69 $2K Nov 19, 2026 Form 4 ↗
Deschenes Roger P.Chief Financial Officer Purchase +9,700 $1.80 $17K Nov 18, 2026 Form 4 ↗
Deschenes Roger P.Chief Financial Officer Purchase +300 $1.79 $537 Nov 18, 2026 Form 4 ↗
Whiting John Kimball IVGeneral Counsel & Secretary Purchase +10.0K $1.96 $20K Nov 16, 2026 Form 4 ↗
Lewis EarlDirector · Director Purchase +8,094 $1.96 $16K Nov 16, 2026 Form 4 ↗
Lewis EarlDirector · Director Purchase +700 $1.95 $1K Nov 16, 2026 Form 4 ↗
Lewis EarlDirector · Director Purchase +1,206 $1.93 $2K Nov 16, 2026 Form 4 ↗
Whiting John Kimball IVGeneral Counsel & Secretary Grant / award Amended +19.3K $0.00 $0 Jun 26, 2026 Form 4 ↗
Panora RobertCOO and President Grant / award Amended +9,671 $0.00 $0 Jun 26, 2026 Form 4 ↗
Lafaille StephenVP of Business Development Grant / award Amended +29.0K $0.00 $0 Jun 26, 2026 Form 4 ↗
Deschenes Roger P.Chief Financial Officer Grant / award Amended +29.0K $0.00 $0 Jun 26, 2026 Form 4 ↗
Rangesh AbinandChief Executive Officer · Director Grant / award Amended +174.1K $0.00 $0 Jun 26, 2026 Form 4 ↗
Whiting John Kimball IVGeneral Counsel & Secretary Grant / award +19.3K — — Jun 26, 2026 Form 4 ↗
Lafaille StephenVP of Business Development Grant / award +29.0K — — Jun 26, 2026 Form 4 ↗
Deschenes Roger P.CAO Grant / award +29.0K — — Jun 26, 2026 Form 4 ↗
Panora RobertCOO and President Grant / award +9,671 — — Jun 26, 2026 Form 4 ↗

Fund Holders

Mutual funds and ETFs holding TGEN · SEC Form N-PORT
FundSharesValue% of fundAs of
VANGUARD TOTAL STOCK MARKET INDEX FUND
VANGUARD INDEX FUNDS
579.8K$3.0M0.00%Jun 30, 2026
Strategic Advisers U.S. Total Stock Fund
Fidelity Rutland Square Trust II
762.9K$2.3M0.00%Aug 31, 2026
VANGUARD EXTENDED MARKET INDEX FUND
VANGUARD INDEX FUNDS
189.2K$987K0.00%Jun 30, 2026
iShares Micro-Cap ETF
iShares Trust
62.5K$326K0.02%Jun 30, 2026
Fidelity Extended Market Index Fund
Fidelity Concord Street Trust
92.1K$282K0.00%Aug 31, 2026
Ultra-Small Company Market Fund
Bridgeway Funds, Inc.
33.0K$173K0.12%Jun 30, 2026
ACUITAS US MICROCAP FUND
FORUM FUNDS II
36.9K$105K0.10%Sep 30, 2026
Gabelli Global Mini Mites Fund
GAMCO Global Series Funds, Inc
20.0K$104K0.39%Jun 30, 2026
Fidelity Total Market Index Fund
Fidelity Concord Street Trust
29.1K$89K0.00%Aug 31, 2026
Embark Small Cap Equity Fund
Harbor Funds II
18.0K$86K0.02%Apr 30, 2026

Mutual funds and ETFs whose N-PORT filings list TGEN's shares (CUSIP 87876P201), each fund at its latest report since Apr 21, 2026, largest positions first. Bonds, options and short positions are left out.

Activist & Passive Stakes

Schedule 13D / 13G beneficial-ownership filings
  • George McCabeSCHEDULE 13G/A · passive (13G) · 1.2M shares4.0%
    Nov 16, 2026 · ↗
  • Portolan Capital Management, LLCSCHEDULE 13G/A · passive (13G) · 1.2M shares4.0%
    Nov 16, 2026 · ↗
  • George McCabeSCHEDULE 13G · passive (13G) · 1.6M shares5.2%
    Jun 10, 2026 · ↗
  • Portolan Capital Management, LLCSCHEDULE 13G · passive (13G) · 1.6M shares5.2%
    Jun 10, 2026 · ↗

Corporate Lobbying

Estimated quarterly lobbying spending reported under the LDA, filings naming TECOGEN INC. as client

No lobbying filings found naming TECOGEN INC. as the client.

Government Contracts

Federal awards to TECOGEN INC. · USAspending

No federal contract awards found for TECOGEN INC..

U.S. Patents

Recent USPTO applications naming TECOGEN INC.

No USPTO patent applications found for TECOGEN INC..

Annual Financials

From TGEN's 10-K filings · XBRL
Fiscal yearFY2025FY2024FY2023FY2022FY2021
Revenue$27.1M$22.6M$25.1M$25.0M$24.4M
Operating income-$8.2M-$4.5M-$4.4M-$2.3M-$1.2M
Net income-$8.2M-$4.8M-$4.6M-$2.4M$3.7M
Diluted EPS-$0.30-$0.19-$0.19-$0.10$0.15
Operating cash flow-$9.9M$4.1M-$818K-$1.4M$465K
Cash and equivalents$12.4M$5.4M$1.4M$1.9M$3.6M
Total assets$37.0M$31.1M$27.8M$28.3M$32.4M
Total liabilities$15.5M$21.0M$13.1M$9.3M$11.2M
Shareholders' equity$21.6M$10.2M$14.7M$19.1M$21.2M

As TECOGEN INC. tagged them in its 10-K filings: totals for the year on the income and cash-flow lines, values at the year's end on the balance-sheet lines. Latest 10-K, filed Mar 19, 2026 ↗

Stock Splits

Every split and reverse split in the price history

No stock splits in TGEN's price history.

Material Events (8-K)

Corporate events filed with the SEC
  • 8-K · Items 2.02, 7.01, 9.01Results of operations · Reg FD disclosureNov 12, 2026
    EDGAR ↗
  • 8-K · Items 8.01, 9.01Other eventsOct 14, 2026
    EDGAR ↗
  • 8-K · Items 8.01, 9.01Other eventsAug 31, 2026
    EDGAR ↗
  • 8-K · Items 2.02, 7.01, 9.01Results of operations · Reg FD disclosureAug 12, 2026
    EDGAR ↗
  • 8-K · Items 5.02Officer / director changeJul 1, 2026
    EDGAR ↗
  • 8-K · Items 5.07Shareholder voteJun 5, 2026
    EDGAR ↗
  • 8-K · Items 2.02, 7.01, 9.01Results of operations · Reg FD disclosureMay 12, 2026
    EDGAR ↗

About TECOGEN INC.

From SEC EDGAR company records
Industry (SIC 3585)Air-Cond & Warm Air Heatg Equip & Comm & Indl Refrig Equip
SectorIndustrials
HeadquartersNORTH BILLERICA, MA
IncorporatedDE
Former namesTECOGEN INC